United States Drug Repositioning Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Drug Repositioning Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Drug Repositioning Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Drug Repositioning Overall Market Size
2.1 United States Drug Repositioning Market Size: 2021 VS 2027
2.2 United States Drug Repositioning Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drug Repositioning Players in United States Market
3.2 Top United States Drug Repositioning Companies Ranked by Revenue
3.3 United States Drug Repositioning Revenue by Companies
3.4 Top 3 and Top 5 Drug Repositioning Companies in United States Market, by Revenue in 2020
3.5 Companies Drug Repositioning Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drug Repositioning Players in United States Market
3.6.1 List of Tier 1 Drug Repositioning Companies in United States
3.6.2 List of Tier 2 and Tier 3 Drug Repositioning Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Drug Repositioning Market Size Markets, 2021 & 2027
4.1.2 Generic Drugs
4.1.3 Clinical Trial Failed Drugs
4.2 By Type - United States Drug Repositioning Revenue & Forecasts
4.2.1 By Type - United States Drug Repositioning Revenue, 2016-2021
4.2.2 By Type - United States Drug Repositioning Revenue, 2022-2027
4.2.3 By Type - United States Drug Repositioning Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Drug Repositioning Market Size, 2021 & 2027
5.1.2 Cardiovascular Diseases
5.1.3 Mental Illness
5.1.4 Cancer
5.1.5 Others
5.2 By Application - United States Drug Repositioning Revenue & Forecasts
5.2.1 By Application - United States Drug Repositioning Revenue, 2016-2021
5.2.2 By Application - United States Drug Repositioning Revenue, 2022-2027
5.2.3 By Application - United States Drug Repositioning Revenue Market Share, 2016-2027
6 Drug Repositioning Companies Profiles
6.1 Teva
6.1.1 Teva Company Details
6.1.2 Teva Business Overview
6.1.3 Teva Drug Repositioning Introduction
6.1.4 Teva Drug Repositioning Revenue in United States Market (2016-2021)
6.1.5 Teva Recent Developments
6.2 Novartis
6.2.1 Novartis Company Details
6.2.2 Novartis Business Overview
6.2.3 Novartis Drug Repositioning Introduction
6.2.4 Novartis Drug Repositioning Revenue in United States Market (2016-2021)
6.2.5 Novartis Recent Developments
6.3 Mylan
6.3.1 Mylan Company Details
6.3.2 Mylan Business Overview
6.3.3 Mylan Drug Repositioning Introduction
6.3.4 Mylan Drug Repositioning Revenue in United States Market (2016-2021)
6.3.5 Mylan Recent Developments
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Details
6.4.2 Johnson & Johnson Business Overview
6.4.3 Johnson & Johnson Drug Repositioning Introduction
6.4.4 Johnson & Johnson Drug Repositioning Revenue in United States Market (2016-2021)
6.4.5 Johnson & Johnson Recent Developments
6.5 Pfizer
6.5.1 Pfizer Company Details
6.5.2 Pfizer Business Overview
6.5.3 Pfizer Drug Repositioning Introduction
6.5.4 Pfizer Drug Repositioning Revenue in United States Market (2016-2021)
6.5.5 Pfizer Recent Developments
6.6 Bausch Health
6.6.1 Bausch Health Company Details
6.6.2 Bausch Health Business Overview
6.6.3 Bausch Health Drug Repositioning Introduction
6.6.4 Bausch Health Drug Repositioning Revenue in United States Market (2016-2021)
6.6.5 Bausch Health Recent Developments
6.7 GSK
6.7.1 GSK Company Details
6.7.2 GSK Business Overview
6.7.3 GSK Drug Repositioning Introduction
6.7.4 GSK Drug Repositioning Revenue in United States Market (2016-2021)
6.7.5 GSK Recent Developments
6.8 ChemRar Group
6.8.1 ChemRar Group Company Details
6.8.2 ChemRar Group Business Overview
6.8.3 ChemRar Group Drug Repositioning Introduction
6.8.4 ChemRar Group Drug Repositioning Revenue in United States Market (2016-2021)
6.8.5 ChemRar Group Recent Developments
6.9 Glenmark
6.9.1 Glenmark Company Details
6.9.2 Glenmark Business Overview
6.9.3 Glenmark Drug Repositioning Introduction
6.9.4 Glenmark Drug Repositioning Revenue in United States Market (2016-2021)
6.9.5 Glenmark Recent Developments
6.10 Fujifilm
6.10.1 Fujifilm Company Details
6.10.2 Fujifilm Business Overview
6.10.3 Fujifilm Drug Repositioning Introduction
6.10.4 Fujifilm Drug Repositioning Revenue in United States Market (2016-2021)
6.10.5 Fujifilm Recent Developments
6.11 Dr. Reddy
6.11.1 Dr. Reddy Company Details
6.11.2 Dr. Reddy Business Overview
6.11.3 Dr. Reddy Drug Repositioning Introduction
6.11.4 Dr. Reddy Drug Repositioning Revenue in United States Market (2016-2021)
6.11.5 Dr. Reddy Recent Developments
6.12 R-Pharma
6.12.1 R-Pharma Company Details
6.12.2 R-Pharma Business Overview
6.12.3 R-Pharma Drug Repositioning Introduction
6.12.4 R-Pharma Drug Repositioning Revenue in United States Market (2016-2021)
6.12.5 R-Pharma Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Drug Repositioning Market Opportunities & Trends in United States Market
Table 2. Drug Repositioning Market Drivers in United States Market
Table 3. Drug Repositioning Market Restraints in United States Market
Table 4. Key Players of Drug Repositioning in United States Market
Table 5. Top Drug Repositioning Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Drug Repositioning Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Drug Repositioning Revenue Share by Companies, 2016-2021
Table 8. Companies Drug Repositioning Product Type
Table 9. List of Tier 1 Drug Repositioning Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Drug Repositioning Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Drug Repositioning Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Drug Repositioning Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Drug Repositioning Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Drug Repositioning Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Drug Repositioning Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Drug Repositioning Revenue (US$, Mn), 2022-2027
Table 17. Teva Company Details
Table 18. Teva Business Overview
Table 19. Teva Drug Repositioning Product
Table 20. Teva Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Teva Recent Developments
Table 22. Novartis Company Details
Table 23. Novartis Business Overview
Table 24. Novartis Drug Repositioning Product
Table 25. Novartis Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Novartis Recent Developments
Table 27. Mylan Company Details
Table 28. Mylan Business Overview
Table 29. Mylan Drug Repositioning Product
Table 30. Mylan Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Mylan Recent Developments
Table 32. Johnson & Johnson Company Details
Table 33. Johnson & Johnson Business Overview
Table 34. Johnson & Johnson Drug Repositioning Product
Table 35. Johnson & Johnson Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Johnson & Johnson Recent Developments
Table 37. Pfizer Company Details
Table 38. Pfizer Business Overview
Table 39. Pfizer Drug Repositioning Product
Table 40. Pfizer Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Pfizer Recent Developments
Table 42. Bausch Health Company Details
Table 43. Bausch Health Business Overview
Table 44. Bausch Health Drug Repositioning Product
Table 45. Bausch Health Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Bausch Health Recent Developments
Table 47. GSK Company Details
Table 48. GSK Business Overview
Table 49. GSK Drug Repositioning Product
Table 50. GSK Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. GSK Recent Developments
Table 52. ChemRar Group Company Details
Table 53. ChemRar Group Business Overview
Table 54. ChemRar Group Drug Repositioning Product
Table 55. ChemRar Group Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. ChemRar Group Recent Developments
Table 57. Glenmark Company Details
Table 58. Glenmark Business Overview
Table 59. Glenmark Drug Repositioning Product
Table 60. Glenmark Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. Glenmark Recent Developments
Table 62. Fujifilm Company Details
Table 63. Fujifilm Business Overview
Table 64. Fujifilm Drug Repositioning Product
Table 65. Fujifilm Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Fujifilm Recent Developments
Table 67. Dr. Reddy Company Details
Table 68. Dr. Reddy Business Overview
Table 69. Dr. Reddy Drug Repositioning Product
Table 70. Dr. Reddy Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Dr. Reddy Recent Developments
Table 72. R-Pharma Company Details
Table 73. R-Pharma Business Overview
Table 74. R-Pharma Drug Repositioning Product
Table 75. R-Pharma Drug Repositioning Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. R-Pharma Recent Developments
List of FiguresFigure 1. Drug Repositioning Segment by Type
Figure 2. Drug Repositioning Segment by Application
Figure 3. United States Drug Repositioning Market Overview: 2020
Figure 4. United States Drug Repositioning Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Drug Repositioning Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Drug Repositioning Revenue in 2020
Figure 7. By Type - United States Drug Repositioning Revenue Market Share, 2016-2027
Figure 8. By Application - United States Drug Repositioning Revenue Market Share, 2016-2027
Figure 9. Teva Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Novartis Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Mylan Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Johnson & Johnson Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Pfizer Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Bausch Health Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. GSK Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. ChemRar Group Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Glenmark Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Fujifilm Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Dr. Reddy Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. R-Pharma Drug Repositioning Revenue Year Over Year Growth (US$, Mn) & (2016-2021)